Announcements Trials
Browse Landscape

Phase

Phase 3 40Phase 2 22Phase 1 9Phase 4 6Phase NA 2Phase 1/2 2

Status

Completed 4Terminated 1Active not recruiting 1

Sponsor Class

OTHER 6INDUSTRY 6

Study Type

Interventional 6

Sponsor

Cancer Type

Breast 6

Conditions

Breast Neoplasms 6Osteoporosis 1Neoplasm Metastasis 1Joint Diseases 1Bone Diseases, Metabolic 1

Interventions

Zoledronic Acid 23Bevacizumab 13nilotinib 12Docetaxel 12Paclitaxel 11Everolimus 11Letrozole 10Imatinib Mesylate 10Capecitabine 10Erlotinib Hydrochloride 9Drug Therapy 9Carboplatin 9pegfilgrastim 8enzalutamide 8Trastuzumab 7Oxycodone 7Nivolumab 7Imiquimod 7Gemcitabine 7Epoetin Alfa 7icotinib 6Rituximab 6Prednisone 6Pemetrexed 6Oxaliplatin 6Leuprolide 6Fulvestrant 6Diclofenac 6Dexamethasone 6Cisplatin 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 4 × INDUSTRY × Anastrozole × Clear all
NCT05161195 2026-04-02

Roll-over Study to Allow Continued Access to Ribociclib

Novartis

Phase 4 Active not recruiting
134 enrolled
Breast

Breast Neoplasms

NCT03220178 2022-01-06

PRECYCLE

Palleos Healthcare GmbH

Phase 4 Terminated
532 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

NCT00544986 2013-01-30

A Prospective,Open-label Study of Anastrozole in Post-menopausal Women With Hormone Sensitive Advanced Breast Cancer

AstraZeneca

Phase 4 Completed
Breast

Breast Neoplasms

NCT00537771 2013-01-25

HEART

AstraZeneca

Phase 4 Completed
384 enrolled 9 charts
Breast

Breast Neoplasms

NCT00323479 2012-04-06

Arthralgia During Anastrozole Therapy for Breast Cancer

AstraZeneca

Phase 4 Completed
114 enrolled 11 charts
Breast

Breast Neoplasms, Joint Diseases

NCT00082277 2011-01-26

SABRE

AstraZeneca

Phase 4 Completed
237 enrolled
Breast

Bone Diseases, Metabolic, Breast Neoplasms, Osteoporosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡